Your browser doesn't support javascript.
loading
The Potential Role of Naringin and Naringenin as Nutraceuticals Against Metabolic Syndrome.
Massaro, Luca; Raguzzini, Anna; Aiello, Paola; Valencia, Débora Villaño.
Afiliação
  • Massaro L; Research Centre for Food and Nutrition, Council for Agricultural Research and Economics (CREA-AN), Rome, Italy.
  • Raguzzini A; Research Centre for Food and Nutrition, Council for Agricultural Research and Economics (CREA-AN), Rome, Italy.
  • Aiello P; Department of Physiology and Pharmacology "V. Erspamer", La Sapienza University of Rome, Rome, Italy.
  • Valencia DV; Health Sciences PhD Program, Universidad Católica de Murcia UCAM, Campus de los Jerónimos n 135, Guadalupe 30107, Murcia, Spain.
Article em En | MEDLINE | ID: mdl-36043734
ABSTRACT
Metabolic syndrome, an increasing problem in western society, is a cluster of conditions that affect cardiovascular health, lipid and glucose management, increasing the risk of heart diseases, stroke and diabetes. Bioactive flavonoids are a great resource of compounds with proven antiinflammatory activities. Naringin, a natural flavanone found in citrus fruits, and its aglycone have demonstrated to ameliorate obesity, dyslipidemia, and insulin resistance in animal models. The principal mechanisms by which these flavonoids exert their action involve AMPK and PPARα up-regulation and the down-regulation of genes involved in lipid metabolism. Although different studies have been carried out to define the pharmacological effects of these flavonoids, their therapeutic use is still limited.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndrome Metabólica / Flavanonas Limite: Animals Idioma: En Revista: Endocr Metab Immune Disord Drug Targets Assunto da revista: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Síndrome Metabólica / Flavanonas Limite: Animals Idioma: En Revista: Endocr Metab Immune Disord Drug Targets Assunto da revista: ALERGIA E IMUNOLOGIA / ENDOCRINOLOGIA / METABOLISMO / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália